These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 134899)
1. Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens. Costall B; Naylor RJ; Pinder RM Eur J Pharmacol; 1976 Sep; 39(1):153-60. PubMed ID: 134899 [TBL] [Abstract][Full Text] [Related]
2. Effects of antagonists upon locomotor stimulation induced by injection of dopamine and Noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Pijnenburg AJ; Honig WM; Van Rossum JM Psychopharmacologia; 1975; 41(2):175-80. PubMed ID: 1153605 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Costall B; Naylor RJ Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Pijnenburg AJ; Honig WM; Van Rossum JM Psychopharmacologia; 1975; 41(2):87-95. PubMed ID: 1098086 [TBL] [Abstract][Full Text] [Related]
5. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines. Costall B; Naylor RJ J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776 [TBL] [Abstract][Full Text] [Related]
6. Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine. Andén NE; Jackson DM J Pharm Pharmacol; 1975 Sep; 27(9):666-70. PubMed ID: 241810 [TBL] [Abstract][Full Text] [Related]
7. Effect of 4-phenyl-1,2,3,4-tetrahydroisoquinoline on ambulation induced by injection of methamphetamine into the nucleus accumbens in rats. Tateyama M; Ohta S; Nagao T; Hirobe M; Ono H Neuropharmacology; 1993 Mar; 32(3):243-8. PubMed ID: 8474620 [TBL] [Abstract][Full Text] [Related]
8. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting. Costall B; Naylor RJ; Cannon JG; Lee T Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988 [TBL] [Abstract][Full Text] [Related]
9. Studies on the behavioural pharmacology of a cyclic analogue of dopamine following its injection into the brains of conscious rats. Elkhawad AO; Woodruff GN Br J Pharmacol; 1975 May; 54(1):107-14. PubMed ID: 1139070 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives. Costall B; Naylor RJ; Pinder RM Psychopharmacology (Berl); 1976 Jul; 48(2):225-31. PubMed ID: 826935 [TBL] [Abstract][Full Text] [Related]
11. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Costall B; Naylor RJ Eur J Pharmacol; 1976 Jan; 35(1):161-8. PubMed ID: 1253817 [TBL] [Abstract][Full Text] [Related]
12. Effects of dopamine receptor stimulants on locomotor activity of rats with electrolytic or 6-hydroxydopamine-induced lesions of the nucleus accumbens. Woodruff GN; Kelly PH; Elkhawad AO Psychopharmacologia; 1976 May; 47(2):195-8. PubMed ID: 1273217 [TBL] [Abstract][Full Text] [Related]
13. The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset. Scraggs PR; Ridley RM Psychopharmacology (Berl); 1979 Mar; 62(1):41-5. PubMed ID: 155838 [TBL] [Abstract][Full Text] [Related]
14. [Effect of Y-516 on the hyperactivity induced by dopamine injected bilaterally into the nucleus accumbens]. Morimoto T; Morimoto Y; Fukuda T; Setoguchi M Nihon Yakurigaku Zasshi; 1990 Aug; 96(2):65-71. PubMed ID: 2227720 [TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Barik S; de Beaurepaire R Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875 [TBL] [Abstract][Full Text] [Related]
16. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Costall B; Domeney AM; Naylor RJ; Tyers MB Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents. Ginos JZ; Doroski D J Pharmacol Exp Ther; 1979 Apr; 209(1):79-86. PubMed ID: 571017 [TBL] [Abstract][Full Text] [Related]
18. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of some new tetrahydroisoquinoline derivatives inhibiting dopamine uptake and/or possessing a dopaminomimetic property. Zára-Kaczián E; György L; Deák G; Seregi A; Dóda M J Med Chem; 1986 Jul; 29(7):1189-95. PubMed ID: 3806569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]